HLA-B* 57: 01 allele prevalence in treatment-Naïve HIV-infected patients from Colombia

E Martínez Buitrago, JM Oñate, JF García-Goez… - BMC infectious …, 2019 - Springer
Abstract Background The HLA-B* 57: 01 allele is associated with a hypersensitivity reaction
to abacavir. Due to the lack of knowledge of HLA-B* 57: 01 prevalence in Colombia, routine …

Frequency of HLA B* 5701 allele carriers in abacavir treated-HIV infected patients and controls from northeastern Brazil

S Crovella, L Biller, S Santos, A Salustiano, L Brandao… - Clinics, 2011 - SciELO Brasil
In clinical practice, using pharmacogenetics has risen in importance since the technologies
for genomic variation searches for different responses to drugs became widespread, easier …

Prevalence of HLA‐B*57:01 allele in Argentinean HIV‐1 infected patients

M Moragas, WH Belloso, MS Baquedano… - Tissue …, 2015 - Wiley Online Library
Hypersensitivity reaction to abacavir (ABC hypersensitivity syndrome, AHS) is strongly
associated with the presence of the HLA‐B* 57: 01 allele. This study was designed to …

The frequency of HLA-B∗ 57: 01 and the risk of abacavir hypersensitivity reactions in the majority population of Costa Rica

E Arrieta-Bolaños, JA Madrigal, SGE Marsh… - Human Immunology, 2014 - Elsevier
Abstract HLA-B∗ 57: 01 is a well-known and cost-effective pharmacogenetic marker for
abacavir hypersensitivity. As with other HLA alleles, there is widespread variation in its …

[HTML][HTML] Identificación del alelo HLA B* 57: 01 en una población militar, de Lima-Perú

G Vilcarino-Zevallosi, S Espetia-Anco… - Revista chilena de …, 2024 - SciELO Chile
Resumen El alelo HLA B* 57: 01 es un marcador genético asociado con la
hipersensibilidad al fármaco anti-retroviral abacavir (ABC) y su frecuencia en la población …

[HTML][HTML] Orientaciones para el manejo ambulatorio de adultos que viven con VIH en Chile

N Rodríguez Ortiz, D Saa Aguilera… - Revista chilena de …, 2024 - SciELO Chile
El enfrentamiento de las personas que viven con VIH es amplio y requiere dedicación en
múltiples dimensiones, más allá de la terapia antirretroviral. Estas recomendaciones …

[HTML][HTML] Human leucocyte antigen B* 57.01 allelic gene is uncommon in Nigerians: An implication for antiretroviral therapy among the HIV/AIDS cohort

TO Owojuyigbe, RA Bolarinwa… - The Indian Journal …, 2024 - pmc.ncbi.nlm.nih.gov
Human leucocyte antigen B*57.01 allelic gene is uncommon in Nigerians: An implication for
antiretroviral therapy among the HIV/AIDS cohort - PMC Skip to main content Here's how you …

The Prevalence of HLA-B* 57 Serotype Associated with Hypersensitivity Reactions in the Treatment of HIV İnfection in the Turkish Population

MA Kizmaz, A Simsek, F Aymak, EH Akalin… - Current HIV …, 2023 - ingentaconnect.com
Objectives: The aim of our study is to reveal the prevalence of HLA-B* 57 in the Turkish
population and to provide new perspectives to physicians starting abacavir therapy in HIV …

[HTML][HTML] Pharmacogenetics of HIV therapy: State of the art in Latin American countries

CA Velozo, FRM Lamarão… - … and molecular biology, 2022 - SciELO Brasil
The use of combined antiretroviral therapy (cART) has resulted in a remarkable reduction in
morbidity and mortality of people living with HIV worldwide. Nevertheless, interindividual …

[HTML][HTML] Consideraciones en la elección de terapia anti-retroviral de primera línea en adultos

ME Ceballos - Revista chilena de infectología, 2013 - SciELO Chile
Consideraciones en la elección de terapia anti-retroviral de primera línea en adultos SciELO -
Scientific Electronic Library Online vol.30 número5 Endoftalmitis endógenas: revisión de una …